E-LIB Suche - Ergebnisse für: Hubalek, Michael

1

Clinical applications of next‐generation sequencing‐based c..:

Klocker, Eva Valentina ; Hasenleithner, Samantha ; Bartsch, Rupert...
https://resolver.sub.uni-goettingen.de/purl?gro-2/143929. , 2024

Link: https://resolver.sub.uni..

2

Cardiac Safety And Long-Term Survival Benefit Of Neoadjuvan..:

Hubalek, Michael
https://openresearchlibrary.org/viewer/68d7f813-f7e7-4838-abc7-8e9979f32c46. , 2017

Link: https://openresearchlibr..

3

Self-reported sexual health: breast cancer survivors compar..:

Oberguggenberger, Anne ; Martini, Caroline ; Huber, Nathalie...
http://sro.sussex.ac.uk/id/eprint/70183/1/Oberguggenberger-self%20reported%20sexual%20health%20BMC%20Cancer%20Aug%202017.pdf. , 2017

Link: http://sro.sussex.ac.uk/..

4

Personalized treatment of women with early breast cancer: a..:

Jahn, Beate ; Rochau, Ursula ; Kurzthaler, Christina...
BMC Cancer. 2017 Oct 16;17(1):685. , 2017

Link: http://hdl.handle.net/18..

5

Adherence evaluation of endocrine treatment in breast cance..:

Oberguggenberger, Anne S ; Sztankay, Monika ; Beer, Beate...
http://www.biomedcentral.com/1471-2407/12/474. , 2012

Link: http://www.biomedcentral..

6

Adherence evaluation of endocrine treatment in breast cance..:

Oberguggenberger Anne S ; Sztankay Monika ; Beer Beate...
http://www.biomedcentral.com/1471-2407/12/474. , 2012

Link: https://doi.org/10.1186/..

7

Role of pertuzumab in the treatment of HER2-positive breast..:

Hubalek, Michael ; Brantner, Christine ; Marth, Christian
info:eu-repo/semantics/altIdentifier/doi/10.2147/BCTT.S23560. , 2012

Link: https://www.dovepress.co..

8

Is the toxicity of adjuvant aromatase inhibitor therapy und..:

Oberguggenberger, Anne ; Hubalek, Michael ; Sztankay, Monika...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10549-011-1378-5. , 2011

Link: https://hal.archives-ouv..

9

Single-agent pegylated liposomal doxorubicin (PLD) in the t..:

Pluschnig Ursula ; Bartsch Rupert ; Hubalek Michael...
http://www.biomedcentral.com/1471-2407/11/373. , 2011

Link: https://doi.org/10.1186/..

10

Influence of HER2 expression on prognosis in metastatic tri..:

S P Gampenrieder 1 ; V Dezentjé 2 ; M Lambertini 3...
info:eu-repo/semantics/altIdentifier/pmid/36563519. , 2023

Link: https://hdl.handle.net/1..

11

Capecitabine in combination with bendamustine in pretreated..:

Gabriel Rinnerthaler ; Simon Peter Gampenrieder ; Andreas Petzer...
https://doi.org/10.1177/17588359211042301. , 2021

Link: https://doi.org/10.1177/..

12

Landscape of HER2-low metastatic breast cancer (MBC): resul..:

Simon Peter Gampenrieder ; Gabriel Rinnerthaler ; Christoph Tinchon...
https://doi.org/10.1186/s13058-021-01492-x. , 2021

Link: https://doi.org/10.1186/..

13

Efficacy and safety of everolimus plus exemestane in patien..:

Guenther G. Steger ; Daniel Egle ; Rupert Bartsch...
http://www.sciencedirect.com/science/article/pii/S0960977620300369. , 2020

Link: https://doi.org/10.1016/..

14

Self-reported sexual health: Breast cancer survivors compar..:

Anne Oberguggenberger ; Caroline Martini ; Nathalie Huber...
http://link.springer.com/article/10.1186/s12885-017-3580-2. , 2017

Link: https://doi.org/10.1186/..

15

Personalized treatment of women with early breast cancer: a..:

Beate Jahn ; Ursula Rochau ; Christina Kurzthaler...
http://link.springer.com/article/10.1186/s12885-017-3603-z. , 2017

Link: https://doi.org/10.1186/..